Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants [version 1; referees: 2 approved]

The direct oral anticoagulants (DOACs) have now supplanted vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE). The DOACs include dabigatran, which inhibits thrombin, and rivaroxaban, apixaban, and edoxaban, which inhibit factor Xa. The DOACs are as effective for the preve...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jeffrey I. Weitz, Iqbal H. Jaffer, James C. Fredenburgh
Formato:	Artigo
Idioma:	Inglês
Publicado em:	F1000 Research Ltd 2017-06-01
coleção:	F1000Research
Assuntos:	Bleeding & Coagulation Disorders Coronary Artery Disease Vascular Diseases (Non-Coronary)
Acesso em linha:	https://f1000research.com/articles/6-985/v1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!